Results 171 to 180 of about 12,992 (201)
Some of the next articles are maybe not open access.
American Journal of Health-System Pharmacy, 2008
The pharmacology, pharmacokinetics, indications, clinical efficacy, adverse effects, drug interactions, and dosage and administration of eculizumab are reviewed.Eculizumab, a recombinant, humanized, monoclonal, immunoglobulin G antibody produced from murine myeloma cells, is the first agent to be approved for labeling by the Food and Drug ...
openaire +2 more sources
The pharmacology, pharmacokinetics, indications, clinical efficacy, adverse effects, drug interactions, and dosage and administration of eculizumab are reviewed.Eculizumab, a recombinant, humanized, monoclonal, immunoglobulin G antibody produced from murine myeloma cells, is the first agent to be approved for labeling by the Food and Drug ...
openaire +2 more sources
Eculizumab treatment for myasthenia gravis subgroups: 2021 update
Journal of Neuroimmunology, 2022Shougang Guo
exaly